Article
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells.
Nature reviews. Cancer - 1 Oct 2019
Keller Laura, Pantel Klaus
Abstract excerpt
Single-cell technologies have contributed to unravelling tumour heterogeneity, now considered a hallmark of cancer and one of the main causes of tumour resistance to cancer therapies. Liquid biopsy (LB), defined as the detection and analysis of cells or cell products released by tumours into the blood, offers an appealing minimally invasive approach that allows the characterization and monitoring of tumour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
